Skip to main content
. Author manuscript; available in PMC: 2024 Jul 15.
Published in final edited form as: Int J Radiat Oncol Biol Phys. 2023 Jan 20;116(4):869–877. doi: 10.1016/j.ijrobp.2023.01.016

Table 1.

Clinical variables and outcomes for 101 young children with intracranial ependymoma.

Number Time
Age at RT
Diagnosis 1.68 years (0.01–3.02 years)
Radiation Therapy 2.12 years (0.89–3.10 years)
Last Follow-up 20.81 years (7.46–26.84 years)
Sex
M 55
F 46
Race/Ethnicity
Asian 4
Black 9
Hispanic 4
Other 4
White 80
Extent of Resection
Gross-total Resection 83
Near-total Resection 7
Sub-total Resection 11
Clinical Target Volume Margin
0.5cm 22
1.0cm 79
Total Dose
54.0 Gy 28
59.4 Gy 73
Tumor Location
Infratentorial 90
Supratentorial 11
Grade
Classic 30
Anaplastic 71
Shunt
None 49
Yes 52
Cause of Death
Tumor Progression 24
High-grade Glioma 6
Necrosis 2
Shunt Failure 1
Anaphylaxis 1
Pattern of Failure
Local 17 2.02 years (0.86–9.46 years)
Distant 11 1.70 years (0.39–4.48 years)
Local and Distant 6 0.89 years (0.63–2.90 years)
Secondary Tumor
Benign Thyroid Nodule 5 14.4 years (4.00–16.19 years)
Meningiomatosis 1 4.92 years
Cholesteatoma 1 13.01 years
Low-grade glioma 1 2.80 years
High-grade Glioma 6 9.79 years (4.05–14.53 years)
Meningioma 7 14.25 years (6.19–18.39 years)
Papillary Thyroid Cancer 3 9.16 years (6.84–11.32 years)
Vestibular Schwannoma 1 11.14 years

Two patients who developed thyroid nodules in addition to meningioma are included.

Two re-irradiated patients who developed high-grade glioma 8.39 and 14.53 years after their initial treatment with radiation therapy are included.